✦ LIBER ✦

The clinical use of LMP2-specific cytotoxic T lymphocytes for the treatment of relapsed EBV +ve Hodgkin disease (HD) and non-Hodgkin lymphoma (NHL)

✍ Scribed by C.M. Bollard; E. Buza; H. Huls; T. Lopez; V. Gresik; J. Chang; S. Gottschalk; G. Carrum; A.P. Gee; M.K. Brenner; C.M. Rooney; H.E. Heslop

Book ID: 116278464
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 67 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2005.11.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of autologous LMP2-specific cyto

The use of autologous LMP2-specific cytotoxic T lymphocytes for the treatment of relapsed EBV+ Hodgkin’s disease and non-Hodgkin’s lymphoma

✍ C.M. Bollard; K.C. Straathof; H. Huls; V. Gresik; G. Carrum; S. Gottschalk; A. G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

25 The use of EBV-specific cytotoxic T l

25 The use of EBV-specific cytotoxic T lymphocytes as adjuvant therapy post stem cell transplant for relapsed EBV-positive Hodgkin disease

✍ C.M. Bollard; K.C. Straathof; H. Huls; K. Lacuesta; M.V. Gresik; G. Carrum; M.K. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 140 KB

The generation of LMP2a-specific cytotox

The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease

✍ Zhen Su; Mario V. Peluso; Silke H. Raffegerst; Dolores J. Schendel; Marie A. Ros 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views